A new concept of bone health

Paving a new way for bone health management
through prevention, early diagnosis of osteoporosis
and lifetime monitoring at the point of care.
Watch the video

A new concept
of bone health

Paving a new way for bone
health management through
prevention, early diagnosis of
osteoporosis and lifetime
monitoring at the point of care.Watch the video

R.E.M.S.® Technology

Radiofrequency Echographic Multi Spectrometry
Radiation-free technology for bone density and quality
assessment at the lumbar vertebrae and the femoral neck.

The technology



Lumbar Vertebrae
Femoral Neck


Bone Density
Bone Quality


A new era in bone densitometry

Revolutionary approach for bone micro-architecture
characterization exploiting the radiofrequency signals
acquired during an echographic scan.
Book your Virtual Demo


The very first radiation-free solution for bone
health assessment at the axial sites through a
very simple and fast echographic scan.
The products







Nothing like before

The new State-of-the-Art in bone densitometry
thanks to the extreme ease and the high performance
setting a new standard in bone health assessment.

The science of excellence

The most important personalities of the world’s scientific community
on the diagnosis of osteoporosis and related bone diseases
share their experience with R.E.M.S. technology.

Prof. Maria Luisa Brandi

Director of Bone Mineral and
Metabolism diseases Unit at
Careggi Hospital in Florence.
Prof. of Endocrinology
Univeristy of Florence.
Watch the Video

Prof. Jean-Yves Reginster

ESCEO President
Head of the bone and
cartilage, Metabolism Unit.
University of Liegi
Liegi, Belgium.
Watch the Video

Prof. Cyrus Cooper

IOF President
Professor of Rheumatology
University of Southampton
Southampton General Hospital
United Kingdom
Watch the Video

Prof. René Rizzoli

Emeritus Professor of Medicine
University Hospitals and
Faculty of Medicine.
Geneva University
Watch the Video

Latest News

Remsify your clinic

The first R.E.M.S. Clinic  We are pleased to announce the opening of the first diagnostic center in Romania entirely dedicated to R.E.M.S technology. At the “Osteodensys” center in Bucharest, bone densitometries are exclusively performed by the R.E.M.S. technology...

Echolight in France

Echolight has always benefited from the highly professional and competent partners for the marketing of the innovative EchoS bone densitometer all over the world, and recently also in France. The high level of innovation achieved through the use of R.E.M.S. technology...

Echolight in Russia

Echolight secured the Russian certification. We are proud to announce that we have obtained the certification for the marketing of our devices in Russia. A further recognition obtained in these days by Roszdravnadzor (Federal Service for Surveillance in Healthcare),...

Echolight in the UK

Echolight continues its expansion around the world. Today EchoS, the only radiation free device for the bone assessment on the lumbar vertebrae and the femoral neck, is marketed in more than 30 countries, thanks to the network of distributors located in different...

Advisory Board Meeting

III Meeting of the Echolight International Scientific Board, 4 February, 2020, Geneva. On February 4th, the III Meeting of the Echolight International Scientific Board was held in the beautiful city of Geneva, chaired by Professor Maria Luisa Brandi, with the special...

Welcome to Professor Cortet

New member of the International Scientific Board. We are pleased to introduce Professor Bernard CORTET as a new member of our International Scientific Advisory Board. All the other board members were pleased to welcome Professor Cortet given his outstanding scientific...

Echolight in Latin America

Echolight in Latin America Echolight’s international expansion continues: it has long since it landed in Latin America. After obtaining important certifications for the marketing of the innovative EchoS device in Mexico (COFEPRIS) and Brazil (ANVISA), today the range...

New scientific paper

New scientific paper on R.E.M.S.: “Radiofrequency Echographic Multi Spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study” New recognition obtained for R.E.M.S. (Radiofrequency Echographic Multi Spectrometry): the new scientific...

FDA Clereance

Echolight obtains FDA Clereance. It’s a great pleasure to announce that Echolight has received the 510(K) approval from the FDA –  U.S. Food and Drug Administration, the governing body that regulates the trade of medical devices within the US market, for its EchoS...